Key result
Abnormally high exertional breathlessness during incremental cycle exercise testing was associated with a significantly higher risk of all-cause mortality (aHR 2.3) compared to normal breathlessness.
Why the study?
Exertional breathlessness is a key cardiorespiratory symptom that can be quantified during incremental exercise testing, but its prognostic significance was unknown.
Does abnormally high exertional breathlessness during incremental cycle exercise testing predict mortality in adults referred for clinical exercise testing?
Population
13,506 adults referred for exercise testing
Comparison
Abnormally high exertional breathlessness vs within normal predicted ranges
Design
Longitudinal cohort study
Follow-up
Median 8.0 years
Authors
Loading...
May identify higher-risk patients on exercise testing; leaves open whether targeting breathlessness improves survival.
Cohort (n=13,506)
No
Does abnormally high exertional breathlessness during incremental cycle exercise testing predict mortality in adults referred for clinical exercise testing?
Hazard Ratio: 2.3 (95% CI 2.1–2.6)
p-value: p=<0.001
Abnormally high exertional breathlessness during routine clinical exercise testing is a strong, independent predictor of all-cause, respiratory, and cardiac mortality.
Elmberg et al. (2024) conducted a cohort in Referred for incremental cycle exercise testing (n=13,506). Abnormally high exertional breathlessness vs. Normal exertional breathlessness was evaluated on All-cause mortality (aHR 2.3, 95% CI 2.1-2.6, p=<0.001). Abnormally high exertional breathlessness during incremental cycle exercise testing was associated with a significantly higher risk of all-cause mortality (aHR 2.3) compared to normal breathlessness.